{
  "name" : "dacemirror.sci-hub.se_journal-article_ee7cd07611ac3327454bab1e4021df58_10.1038@s12276-019-0226-2.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Systems biology approaches to investigating the roles of extracellular vesicles in human diseases",
    "authors" : [ "András Gézsi", "Árpád Kovács", "Tamás Visnovitz" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : "Introduction",
      "text" : "The rapidly emerging field of extracellular vesicles (EVs)\nhas led to paradigm shifts in many different areas of biology and biomedicine. The release of EVs, originally thought to only act to remove harmful substances from cells, has been shown to have many more functional consequences and a wide range of implications for biomedicine. To understand the structure and function of EVs, the initial biochemical targeted approaches rapidly progressed to bias-free large-scale analyses using systems biology and bioinformatics. In 2009, the first manually curated database of EV proteins, RNA and lipids, ExoCarta1 (http://www.exocarta.org/), was launched. It was\nfollowed by two additional databases including Vesiclepedia2,3 (http://www.microvesicles.org/) and EVpedia4,5\n(http://student4.postech.ac.kr/evpedia2_xe/xe/). These are repositories of RNA, protein, lipid, and metabolite datasets. Given that preanalytical parameters may play important roles in the quality of EV preparations, database entries should be interpreted with caution, and special attention has to be paid to preanalytical conditions. Recently, gene ontology has been extended to the context of EV communication, owing to increased recognition of the importance of the EV field6. Furthermore, bioinformatic tools that can be used to analyze EV datasets have become available7,8. Future directions may include the following: (i) systems biology analyses after more standardized EV preanalytics, (ii) multiomics analyses of EV samples (combinations of different -omic groups used for the analysis), and (iii) the determination of disease-specific EV molecular patterns/networks composed of different molecule types. Additionally, systems\n© The Author(s) 2019 OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.\nCorrespondence: Edit I. Buzás (buzas.edit@med.semmelweis-univ.hu) 1Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary 2MTA-SE Immune-Proteogenomics Extracellular Vesicle Research Group, Budapest, Hungary Full list of author information is available at the end of the article.\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology\n12 34\n56 78\n90 () :,;\n12 34\n56 78\n90 () :,; 1 2 3 4 5 6 7 8 9 0 () :,; 12 34 56 78 90 () :,;\nbiology approaches may be extended to novel fields such as image-based systems biology. Advancements in the analysis of complex biological\nsystems such as EVs will help to reveal the biological significance of these recently discovered structures and exploit their diagnostic and/or therapeutic potential."
    }, {
      "heading" : "EV proteomics",
      "text" : "To date, the best characterized EV cargo is EV-\nassociated protein molecules. Proteomics analysis of EVs has been made available on MS-based technological platforms. Proteomic analyses of EVs have been reviewed extensively elsewhere9,10 and are not the focus of the present article. Of note, thousands of proteins have been identified in various EV subtypes, and disease-specific proteome alterations have also been identified11–14. The potential for EV proteins to be used as monitoring tools for disease progression has also been successfully studied15. In addition, unconventional membrane protein orientation has been described in EVs16. The topology of various EV-associated proteins remains a very important hot topic because it influences target cell recognition by different EV subtypes and the signal transduction pathways induced by EVs."
    }, {
      "heading" : "EV transcriptomics",
      "text" : "A plethora of studies confirmed the feasibility of using\nhigh-throughput transcriptomic methods for EVs (such as microarrays and next-generation sequencing; see\nTable 1)17–19, and these approaches have been used successfully to characterize the healthy circulating20,21, urine20,22, cerebrospinal fluid23, or saliva24,25 EV RNA cargo. The first study exploring the physiological miRNA pattern of circulating EVs was published in 200826. In the following years, the heterogeneity of circulating EV transcriptional landscapes was analyzed and revealed the presence of many different RNA types, including tRNA, miRNA, Y-RNA, mRNA, SRP-RNA, rRNA, lncRNA, piRNA, snRNA, snoRNA, and scaRNA17,20,21. In vitro studies further suggested that various types of RNA molecules identified in EVs were specifically shuttled into EV subsets27. A reference dataset for miRNA profiling in whole blood, peripheral blood cells, serum, and EVs was also published28. EV transcriptomics is particularly useful in the study of complex diseases because it assists in the identification of novel biomarkers (Table 1). The biomarker potential of EVs has been highlighted by high-throughput studies; however, the analysis of a single subtype of EVs29 instead of bulk EV ‘omics’ analyses may yield more targeted results and suggest novel therapeutic strategies."
    }, {
      "heading" : "EV metabolomics",
      "text" : "Metabolomics involves the simultaneous detection and\nanalysis of a large number of small molecules (<2000 Da)\nfrom biological samples30. The relatively low sensitivity of NMR to detect metabolites in EV samples (which are usually available in low amounts) does not allow detailed analysis of the EV metabolome. However, with advances in the available methodological platforms (e.g., UltraPerformance Liquid Chromatography-Mass Spectrometry, UPLC MS), numerous studies have performed detailed analyses of the EV metabolome31–34. Interestingly, EVs have been shown to function as independent metabolic units35 and to modify the metabolome of their body fluid environment36,37 or to induce metabolic changes in recipient cells38."
    }, {
      "heading" : "EV lipidomics",
      "text" : "EV lipidomics (see Table 2) is a relatively new field\nmainly because the amount of an EV sample is usually very limited, and novel techniques with increased sensitivity have only recently become available to EV researchers. In the twentieth century and in the first decade of the twenty-first century, thin layer chromatography (TLC) was widely used, and it was essentially the only technique available that enabled the study of the lipid composition of EV membranes. TLC is an easy and straightforward method and does not require expensive equipment. However, the data collected in TLC experiments are very limited. Only a few lipid forms (main classes) can be separated with the help of external lipid standards. Since 2004, the application of different liquid chromatography technologies have been reported. The sensitivity and reproducibility of these experiments were significantly improved compared to those of the TLC methods, but the number of detectable lipid species was still very limited. Revolutionary development began in the early 2010s with MSbased methods, when real EV lipidomics began. The different MS-based techniques made it possible to determine the different acyl chains of membrane lipids (not just the major lipid types based on the head groups). The number of complex lipidomic studies started to increase significantly in 2016, and an exponential growth of the field is expected to come in the next few years."
    }, {
      "heading" : "EV glycomics",
      "text" : "Glycomics in general show a relative backlog compared\nto other omic fields, such as genomics or proteomics (see Table 3). This is possibly due to the complexity of carbohydrate structures and the lack of sensitive and simple high-throughput methods for glycan analysis that caused a significant delay in the development of glycomics. For glycosylation analyses of EVs, lectin-based microarrays, and high resolution MS analyses have been used, and these approaches provide evidence of EV-specific glycosylation patterns.\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology\nTa b le\n1 Tr an\nsc ri p to m ic s of\np at h ol og\nic al\nco n d it io n -d er iv ed\nEV s\nD is ea\nse /p at ho\nlo g ic al\nco nd\nit io n\nB io lo g ic al\nfl ui d\nEV tr an\nsc ri p to m ic s\nA p p lie\nd m et ho\nds Pu\nb lic at io n\nM yc ob\nac te riu\nm tu be\nrc ul os is In fe ct io n\nSe ru m\nm RN\nA ,m\niR N A ,s nR\nN A ,s no\nRN a, nc RN\nA ,\nRN A -S eq\n69\nH an d,\nfo ot ,a nd\nm ou\nth di se as e\nSe ru m\nm iR N A\nH um\nan m iR N A m ic ro ar ra y\n70\nTy pe\n1 di ab et es\nm el lit us\nU rin\ne m iR N A\nRN A -S eq\n71\nTy pe\n2 di ab et es\nm el lit us\nPl as m a\nm iR N A\nFo cu s m iR N A PC\nR pa ne\nl 72\nH ea rt fa ilu re\naf te r ac ut e m yo ca rd ia li nf ar ct io n\nSe ru m\nm iR N A\nm iR N A m ic ro ar ra y\n73\nPr os ta te\nca nc er\nU rin\ne m RN\nA W ho\nle -g en\nom e ge\nne ex pr es si on\ndi re ct\nhy br id iz at io n\n74\nBe ni gn\npr os ta te\nhy pe\nrp la si a\nU rin\ne m RN\nA W ho\nle -g en\nom e ge\nne ex pr es si on\ndi re ct\nhy br id iz at io n\n74\nBr ea st ca nc er\nSe ru m\nm iR N A\nSm al lR\nN A se qu\nen ci ng\n75\nBr ea st in va si ve\nlo bu\nla r ca rc in om\na Pl as m a\nm RN\nA RN\nA -S eq\n76\nC ol or ec ta lc ar ci no\nm a\nPl as m a an d se ru m\nm iR N A\nH um\nan m iR N om\ne pa ne\nls Ia nd\nII (V er .3 )\n77\nO va ria n ca nc er\nPl as m a\nRN A\nM ic ro ar ra y an al ys is\n78\nSe ro us\npa pi lla ry\nad en\noc ar ci no\nm a of\nth e ov ar y\nSe ru m\nm iR N A\nM ic ro ar ra y an al ys is\n79\nO va ria n ca rc in om\na Pe rit on\nea lo\nr pl eu ra le\nffu si on\nm iR N A\nTa qM\nan m ic ro RN\nA ar ra y A\n80\nLu ng\nad en\noc ar ci no\nm a\nPl as m a\nm iR N A\nm iR C U RY -h um\nan -p an el -I + IIV1 .M\n81\nLu ng\nad en\noc ar ci no\nm a\nPl as m a\nm iR N A\nm iR N A m ic ro ar ra y\n82\nM el an om\na Vi tr eo\nus hu\nm or\nan d se ru m\nm iR N A\nTa qM\nan lo w\nde ns ity\nar ra y\n83\nPa nc re at ic ob\nili ar y ca nc er s\nPl eu ra lfl\nui d an d pl as m a\nm RN\nA Tr an sc rip\nto m e se qu\nen ci ng\n53\nO st eo\nsa rc om\na Pl as m a\nm RN\nA ,r RN\nA ,t RN\nA ,n\ncR N A\nRN A -S eq\n84\nG lio bl as to m a m ul tif or m e\nSe ru m\nm RN\nA A gi le nt\n4 × 44\nK hu\nm an\nm ic ro ar ra ys\n85\nYo un\ngO ns et\nA lz he\nim er ’s D is ea se\nC er eb\nro sp in al fl ui d\nm iR N A\nH um\nan m iR N om\ne pa ne\nls I+\nII (V 4. M )\n86\nM ul tip\nle sc le ro si s\nPl as m a\nm iR N A\n3D -G en\ne H um\nan m iR N A ol ig o ch ip\n87\nRe la ps in gre m itt in g m ul tip\nle sc le ro si s\nSe ru m\ntR N A ,t RN\nA -li ke ,r fa m ,m\niR N A ,l in cR N A ,s ca RN\nA ,r RN\nA ,\npi RN\nA ,\nXR N A RN\nA -s eq\n88\nC ar di ac\nal lo gr af t re je ct io n\nSe ru m\nm iR N A\nFo cu s hu\nm an\nm ic ro RN\nA PC\nR 89\nC hr on\nic lu ng\nal lo gr af t dy sf un\nct io n\nBr on\nch oa lv eo\nla r la va ge\nfl ui d\nEx os om\nal sh ut tle\nRN A\nRN A -s eq\n90\nO lig oa st he\nno zo os pe\nrm ia\nSe m in al pl as m a\nm iR N A\n60 K m ic ro ar ra y\n91\nSa lt se ns iti vi ty\nof bl oo\nd pr es su re\nU rin\ne m iR N A\nm iR N A m ic ro ar ra y\n92\nPo st va se ct om\ny Se m in al pl as m a\nm iR N A\nm iR N A m ic ro ar ra y\n93\nPo st ga st ric\nby pa ss\nsu rg er y\npl as m a an d se ru m\nm iR N A\nm iR N A m ic ro ar ra y\n29\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology"
    }, {
      "heading" : "EV genomics",
      "text" : "Some of the EVs carry DNA that may range in size from 100 base pairs to several kilobase pairs39 or even fragments up to 2 million base pairs long40. EV-associated DNA may be single-stranded DNA, mitochondrial DNA, or double-stranded DNA39,41,42. The DNA content associated with EVs (termed EV-DNA) may be transported within the lumen of EVs39,40; however, recent studies have shown that, depending on the biological context, EVDNA can also be found attached to the outer surface of EVs43–46. Several studies have shown that EV-DNA spans\nsequences across all chromosomes of genomic DNA (gDNA)39,40,47. Sequences of mitochondrial DNA (mtDNA) may or may not be present depending on the context and/or cell line39. Other studies have shown that selective sorting of specific DNA sequences may occur. For example, a study investigating different prostate cancer cell-derived EV subpopulations showed that different EVs carried different gDNA contents48. Another study that investigated the EVs of healthy individuals provided evidence of an uneven representation of the human genome and even detected EV-DNA of bacterial origin46. Nevertheless, very little is currently known about the mechanisms of DNA packaging or selective sorting of DNA into EVs. At present, the functional significance of EV-DNA is\nlargely unknown. A recent study has shown that surfacebound EV-DNA plays a significant role in the binding of EVs to fibronectin45, an extracellular matrix glycoprotein that is of vital importance in processes associated with tumor progression49. Generally, surface-bound molecules\nare responsible for the binding of EVs to target cells or to the extracellular matrix50. Therefore, it is likely that exofacial EV-DNA may have some physiological significance for the recipient cells. Additionally, it has been shown that oncogenes can be transferred from donor to recipient cells; however, contradictory results have been reported regarding whether cancer cell-derived EV-DNA is functional in the recipient cells. In a study, the EVmediated spread of oncogenes was shown to promote disease progression in mice51. Another study showed that EVs containing oncogenic H-ras failed to produce a permanent tumorigenic conversion of primary and immortalized fibroblasts52. Several studies have shown that EV-DNA reflects the parental cell gDNA both qualitatively39,47,53–58 and quantitatively40,42. Therefore, the analysis of circulating EV-DNA may have substantial diagnostic potential. Moreover, the analysis of genomic mutations may prove to be superior to the analysis of the RNA transported by EVs, as DNA is intrinsically more stable than RNA.\nSystems biology approaches show relationships between genes involved in EV biogenesis and diseases Finally, it is possible to gain information about the role\nof EVs through a systems biology analysis of public transcriptomic and genomic data, as well as different types of biomedical data. Our goal was to determine the relationships between key genes involved in EV biogenesis and diseases using systems biology approaches. We investigated whether a selected group of the proteins from among those reported to play a role in the biogenesis or\nThin layer chromatography (TLC) 198794; 198995; 199596; 200297; 200498; 200999; 2010100; 2015101,102; 2017103 sEV94–96,98–103, mEV96,98\nLiquid chromatography (HPLC, GLC, LC-CAD) 2004;98,104 2010;100 2011;105 2013;106 2015;102 2017107 sEV98,100,102,104–106, mixed EV107\nMS-based techniques (ESI MS/MS; GC MS; LC\nMS/MS)\n2010100, 2012108; 2013106,109–111; 2015112,113; 2016114–116; 2017117–119; 2018120–123 sEV100,106,108–111,113,114,116,117,119–124, mEV117,118\nTable 3 Glycomic technologies used for EV analysis\nTechnique for glycomic analysis Publications Pros and cons\nLectin-based microarrays 125–129 Unbiased glycan analysis of carbohydrates on the surfaces of intact EVs\nHigh resolution MS 130–134 Requires expensive equipment. Data analysis may be time consuming\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology\nsecretion of EVs were associated with phenotypes and were enriched in publicly available transcriptomic databases. Based on the literature, without a claim of completeness,\nwe have compiled lists of proteins that have been reported to play roles in the biogenesis (see Tables S1 and S3) and secretion of EVs (see Table S2). We defined five partly overlapping gene sets from among these lists, namely, genes involved in EV biogenesis and secretion, EV biogenesis, exosome biogenesis, microvesicle biogenesis, and exosome secretion. We used these sets as inputs for the different analyses. Of note, the term “exosomes” refers here to small (50–150 nm in diameter) EVs that originate from the multivesicular body, whereas the designation “microvesicles” is used for EVs shed from the plasma membrane that are usually of medium size (100–1000 nm in diameter). The Quantitative Semantic Fusion (QSF) System59 is\nan extensible framework that incorporates distinct annotated semantic types (also called entities) and links between them by integrating different data sources from the Linked Open Data world. The QSF System then enables the users to quantitatively prioritize a freely chosen entity based on evidence propagated from any other entity or possibly multiple entities through the connecting links (see Figure S1). Currently, the system contains genes, taxa, diseases, phenotypes, disease categories (UMLS semantic types and MeSH disease classes), pathways, substances, assays, cell lines, and the targets of the compounds. Links define associations between entities. For example, genes and pathways are connected with a link that represents gene-pathway associations. To enable cross-species information fusion, we also added gene orthologue links. The most important gene-disease associations identified in this research are from the DisGeNet60 database. This database integrates many other sources of information\n(e.g., OMIM, GWAS Catalog, OrphaNet, Mouse Genome Database, and Rat Genome Database). We constructed three different computation graphs that\nwere used to detect known and predicted disease and phenotype associations (see Fig. 1). All three models can be used to answer the question of whether the genes involved in the biogenesis or secretion of EVs are functionally altered (for example, due to significant polymorphisms, mutations, or changes in the gene expression or the amount of protein produced), and, if so, which diseases are associated with these changes. This can also elucidate the pathomechanisms underlying the association between diseases or phenotypes and EVs. The first model, based on gene-disease associations\nknown in the literature (based on the data sources in the DisGeNet database), prioritizes the diseases and related phenotypes that can be linked to important genes relevant to EVs. In the second model, molecular pathway associations were used to expand the range of genes to include disease-associated genes that are in the same molecular pathways as the genes that are important for EVs. In the third model, we used the molecular pathway information from different species to predict the diseases associated with human genes the orthologues of which in other species are in the same molecular pathways as the orthologues of the human genes important for EVs. We used the QSF System to quantitatively prioritize\ndiseases and phenotypes that are associated with the five gene sets of genes known to be involved in the biogenesis and/or secretion of different types of EVs. First, we used a model that exploited the gene-disease associations already known in the literature. The top 20 diseases that are associated with genes that are involved either in the biogenesis or the secretion of EVs are shown in Table 4. The top 20 phenotypes are shown in Table S4. EV biogenesis genes are significantly associated with several diseases, including several tumors, such as mammary neoplasms\nGene Disease Pheno-type\nGene Pathway Gene Disease Pheno-type\nGene Pathway (Other species) Gene Disease Pheno-type Gene (Other species) Gene (Other species)\nOrtholog Ortholog\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology\n(microvesicle biogenesis: p= 0.03; Exosome secretion: p < 0.01) and melanoma (microvesicle biogenesis: p= 0.02); pathologic functions, such as neoplasm invasiveness (EV biogenesis and secretion: p < 0.01) and neoplasm metastasis (EV biogenesis: p= 0.03); and cardiovascular diseases, such as myocardial reperfusion injury (microvesicle biogenesis: p < 0.01). The most relevant phenotypes include frontotemporal dementia (exosome biogenesis: p < 0.01), lack of insight (exosome biogenesis: p < 0.01), and autoimmune neutropenia (exosome secretion: p= 0.01). Pathway-mediated analysis (i.e., determining which diseases are associated with genes that participate in the same pathway as EV biogenesis genes) indicated possible associations of EVs with many common diseases (see Table S5 and Table S6), such as diabetes (microvesicle biogenesis: p < 0.01), Alzheimer’s disease (EV biogenesis and secretion: p < 0.01), and obesity (microvesicle biogenesis: p= 0.02). Cross-species pathway-mediated analysis indicated the possible association of EVs with several tumors (see Tables S7 and S8), such as mouth neoplasms\nDegenerative\npolyarthritis\n0.72 0.00 0.55 0.00 0.34 0.04 0.41 0.03 1.00 0.00\nNeoplasm invasiveness 0.71 0.00 0.82 0.00 0.33 0.18 0.83 0.00 0.60 0.00\nSquamous cell\ncarcinoma\n0.66 0.00 0.37 0.02 0.04 0.27 0.52 0.00 0.84 0.00\nEsophageal neoplasms 0.60 0.00 0.56 0.02 0.01 0.22 0.83 0.00 0.60 0.00\nDiabetes mellitus,\nexperimental\n0.59 0.00 0.64 0.09 0.97 0.01 0.53 0.00\nNeoplasm metastasis 0.53 0.00 0.82 0.03 0.53 0.03 0.62 0.03 0.29 0.07\nLiver carcinoma 0.52 0.02 0.10 0.39 0.04 0.43 0.10 0.15 0.81 0.00\nNon-small cell lung\ncarcinoma\n0.49 0.00 0.29 0.12 0.00 0.91 0.45 0.03 0.61 0.00\nMouth neoplasms 0.48 0.00 0.80 0.00\nMelanoma 0.47 0.02 0.68 0.02 0.39 0.10 0.55 0.02 0.30 0.05\nAnimal mammary\nneoplasms\n0.47 0.00 0.79 0.00\nJuvenile-onset dystonia 0.47 0.01 0.79 0.00\nIGA glomerulonephritis 0.44 0.07 1.00 0.00 1.00 0.05 0.28 0.32 0.20 0.12\nMammary neoplasms,\nexperimental\n0.43 0.01 0.18 0.28 0.28 0.19 0.60 0.00\nAlzheimer’s disease 0.43 0.06 0.32 0.15 0.01 0.74 0.48 0.06 0.49 0.02\nProstatic neoplasms 0.42 0.11 0.07 0.65 0.01 0.77 0.10 0.30 0.65 0.00\nStomach neoplasms 0.41 0.05 0.07 0.49 0.02 0.46 0.07 0.20 0.63 0.00\nAdenocarcinoma 0.40 0.01 0.33 0.08 0.00 0.75 0.48 0.02 0.43 0.01\nMyocardial reperfusion\ninjury\n0.39 0.02 0.64 0.00 0.22 0.17 0.97 0.00 0.20 0.11\nFor each gene list (columns), the relevance score is the normalized relevance score computed by the first model (see Fig. 1). P-values were computed by permutation tests. The top 20 most relevant diseases are reported based on the gene list of EV biogenesis and secretion\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology\nTa b le\n5 En\nri ch\nm en\nt of\nd if fe re n t se ts\nof ke\ny EV\ng en\nes in\nva ri ou\ns g en\ne ex\np re ss io n ex\np er im\nen ts\nG EO ac ce ss io n\nSt ud\ny C on\ntr as t\nEx tr ac el lu la r ve\nsi cl e\nb io g en\nes is\nan d se cr et io n\nEx tr ac el lu la r ve\nsi cl e\nb io g en\nes is\nEx os om\ne\nb io g en\nes is\nM ic ro ve\nsi cl e\nb io g en\nes is\nEx os om\ne se cr et io n\nG SE 13 57 6\nXe no\ngr af te d le uk em\nia sa m pl es\nw ith\ndi ffe re nt\ntim e to\nle uk em\nia\nph en\not yp es\nN o re la ps e vs .e ar ly re la ps e\n1. 16\nE11\n1. 24\nE05\n3. 27\nE04\n1. 14\nE02\n2. 66\nE06\nN o re la ps e vs .l at e re la ps e\n3. 46\nE03\n1. 56 E01\n2. 53 E01\n7. 43 E01\n9. 51 E02\nN o re la ps e vs .r el ap se\n7. 85\nE15\n5. 25\nE07\n2. 30\nE05\n3. 78\nE03\n6. 53\nE08\nEa rly\nre la ps e vs .l at e\nre la ps e\n5. 11\nE03\n1. 71 E01\n3. 24 E01\n7. 79 E01\n1. 37 E01\nG SE 69 19\nN or m al an d pr os ta te\ntu m or\ntis su es\nH ea lth\ny vs .t um\nor 1. 59\nE03\n3. 45\nE02\n4. 29 E01\n9. 54 E02\n8. 41\nE04\nTu m or\nvs .a dj ac en\nt 4. 70\nE03\n6. 29 E01\n9. 88 E01\n8. 70 E01\n1. 34\nE03\nTu m or\nvs .m\net as ta tic\n1. 58\nE09\n9. 75\nE04\n1. 87\nE02\n8. 04\nE06\n4. 55\nE11\nG SE 41 15\nSm ok er s w ith\nsu sp ec te d lu ng\nca nc er\nN o ca nc er\nvs .c an ce r\n5. 53\nE25\n3. 48\nE08\n3. 37\nE04\n8. 37\nE06\n2. 40\nE21\nG SE 54 51 4\nSu rv iv or s an d no\nns ur vi vo rs of\nse ps is\nH ea lth\ny vs .s ur vi vo r\n1. 32\nE16\n1. 99\nE03\n2. 81\nE02\n9. 59 E02\n1. 51\nE15\nH ea lth\ny vs .n\non su rv iv or\n7. 00\nE09\n1. 79\nE05\n1. 67\nE03\n4. 87\nE05\n1. 26\nE07\nH ea lth\ny vs .s ep\nsi s\n(s ur vi vo r+\nno ns ur vi vo r)\n1. 92\nE25\n2. 11\nE05\n2. 00\nE03\n5. 41 E01\n3. 42\nE23\nN on\nsu rv iv or\nvs .s ur vi vo r\n3. 79\nE25\n9. 98\nE05\n1. 28\nE03\n3. 64\nE09\n3. 99\nE24\nG SE 43 69 6\nN or m al co nt ro ls ,m\nild -m\nod er at e\nas th m at ic pa tie nt s an d se ve re as th m at ic pa tie nt s\nC on\ntr ol\nvs .m\nod er at e\nas th m a\n9. 78 E01\n9. 21 E01\n9. 94 E01\n9. 21 E01\n1. 00 E + 00\nC on\ntr ol vs .s ev er e as th m a\n5. 62 E02\n1. 96 E01\n3. 43 E01\n3. 34 E01\n5. 62 E02\nC on\ntr ol\nvs .a st hm\na\n(m od\ner at e + se ve re )\n4. 40 E01\n6. 16 E01\n8. 09 E01\n7. 70 E01\n3. 96 E01\nM od\ner at e vs .s ev er e\nas th m a\n2. 54 E01\n3. 53 E01\n4. 23 E01\n5. 08 E01\n3. 74 E01\nVa lu es\nin th e ta bl e re pr es en\nt Be\nnj am\nin i-H\noc hb\ner g ad\nju st ed\npva lu es\nfo r en\nric hm\nen t co m bi ni ng\nth e re su lts\nof 10\ndi ff er en\nt en\nric hm\nen t al go\nrit hm\ns. St at is tic al ly\nsi gn\nifi ca nt\npva lu es\n(< 0. 05\n) ar e in\nbo ld\nOfficial journal of the Korean Society for Biochemistry and Molecular Biology\n(exosome secretion: p < 0.01) and tongue neoplasms (exosome secretion: p < 0.01) and several other diseases and conditions. Next, we downloaded and reanalyzed five large publicly\navailable microarray data sets from the Gene Expression Omnibus (GEO) that represent various diseases (accessions: GSE13576, GSE6919, GSE4115, GSE54514, and GSE43696). Then, we computed the enrichment of the five key EV gene sets and all KEGG pathways in the various contrasts of the differential expression analyses. The statistical analyses were performed in R statistical language61. We used the limma62 and EGSEA63 packages for the microarray and enrichment analysis, respectively. The Ensemble of Gene Set Enrichment Analysis\n(EGSEA) utilizes and combines the analysis results of many prominent gene set enrichment algorithms to calculate the collective significance score for a given gene set in the generally long lists of genes that arise from a differential expression analysis. We reanalyzed five publicly available gene expression\nexperiments using contrasts defined by the authors of these experiments, and then we computed the enrichment of the five key EV gene lists using the EGSEA method based on these contrasts (i.e., gene expression signatures relevant for a specific biological process). The key EV gene sets were statistically significantly\nenriched in many of the analyzed contrasts (see Table 5). Meyer et al. investigated the engraftment properties and\nimpact on outcomes of 50 pediatric acute lymphoblastic leukemia samples transplanted into NOD/SCID mice64. They found that the time to the development of leukemia (i.e., weeks from transplant to overt leukemia) was strongly associated with the risk of early relapse. We found that the differentially expressed genes between the no relapse and the early relapse groups were significantly enriched for key EV genes as well. Yu et al. performed a comprehensive gene expression\nanalysis on 152 human samples, including prostate cancer tissues, prostate tissues adjacent to tumor, and organ donor prostate tissues, obtained from men of various ages65. The differentially expressed genes between the nonmetastatic tumor samples and the metastatic tumor samples were significantly enriched for all key EV gene sets. Spira et al. compared gene expression data from smo-\nkers with lung cancer with samples from smokers without lung cancer66. This allowed them to generate a diagnostic gene expression profile that could distinguish between the two classes. We found that all EV gene sets were significantly enriched in the gene expression profile comparing smokers with and without lung cancer. Parnell et al. performed gene expression profiling of\nwhole blood to monitor immune dysfunction in critically ill septic patients67. We found that all gene expression signatures comparing healthy controls with sepsis\nsurvivors, healthy controls with nonsurvivors, and nonsurvivors with survivors were significantly enriched for EV genes. Voraphani et al. compared the gene expression profiles of\nairway epithelial and bronchoalveolar lavage cells of healthy controls, mild-moderate asthmatic patients, and severe refractory asthmatic patients, respectively68. We found no enrichment in the different gene expression signatures. Genes that have been reported to participate in the\nbiogenesis or secretion of EVs are significantly associated with numerous common diseases, including different types of tumors and cardiovascular diseases, which further emphasizes the key role of EVs in human health and disease."
    }, {
      "heading" : "Acknowledgements",
      "text" : "This work was supported by the National Scientific Research Program of Hungary (OTKA) grant no. 112872, 111958 and 120237, National Heart Program (NVKP_16-1-2016-0017) and the ÚNKP-18-3-IV-SE-14 New National Excellence Program of the Ministry of Human Capacities. Additional funding included VEKOP-2.3.2-16-2017-000002 and VEKOP-2.3.3-15-2017-00016, Higher Education Institutional Excellence Program – Therapeutic Development, STIA2017 and H2020-MSCA-ITN-2017-722148 TRAIN EV. The development of the Quantitative Semantic Fusion System was supported by the European Union’s Horizon 2020 research and innovation program “Ageing with Elegans” (Grant agreement No 633589)."
    }, {
      "heading" : "Author details",
      "text" : "1Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary. 2MTA-SE Immune-Proteogenomics Extracellular Vesicle Research Group, Budapest, Hungary. 3Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary"
    }, {
      "heading" : "Conflict of interest",
      "text" : "The authors declare that they have no conflict of interest."
    }, {
      "heading" : "Publisher’s note",
      "text" : "Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nSupplementary information accompanies this paper at https://doi.org/ 10.1038/s12276-019-0226-2.\nReceived: 11 December 2018 Accepted: 12 December 2018"
    } ],
    "references" : [ {
      "title" : "a compendium of exosomal proteins and RNA",
      "author" : [ "S. Mathivanan", "Simpson", "R.J. ExoCarta" ],
      "venue" : "Proteomics 9, 4997–5000",
      "citeRegEx" : "1",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "a compendium for extracellular vesicles with continuous community annotation",
      "author" : [ "Kalra", "H. et al. Vesiclepedia" ],
      "venue" : "PLoS Biol. 10, e1001450",
      "citeRegEx" : "2",
      "shortCiteRegEx" : null,
      "year" : 2012
    }, {
      "title" : "a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles",
      "author" : [ "Pathan", "M. et al. Vesiclepedia 2019" ],
      "venue" : "Nucleic Acids Res. 47, D516–D519",
      "citeRegEx" : "3",
      "shortCiteRegEx" : null,
      "year" : 2019
    }, {
      "title" : "an integrated database of high-throughput data for systemic analyses of extracellular vesicles",
      "author" : [ "Kim", "D.-K. et al. EVpedia" ],
      "venue" : "J. Extracell. Vesicles 2, 20384",
      "citeRegEx" : "4",
      "shortCiteRegEx" : null,
      "year" : 2013
    }, {
      "title" : "a community web portal for extracellular vesicles research",
      "author" : [ "Kim", "D.-K. et al. EVpedia" ],
      "venue" : "Bioinformatics 31, 933–939",
      "citeRegEx" : "5",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Extending gene ontology in the context of extracellular RNA and vesicle communication",
      "author" : [ "Cheung", "K.-H" ],
      "venue" : "J. Biomed. Semant. 7,",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2016
    }, {
      "title" : "Exosomes and Microvesicles",
      "author" : [ "S. Keerthikumar", "L. Gangoda", "S. Gho Y.", "In Mathivanan S. Bioinformatics Tools for Extracellular Vesicles Research." ],
      "venue" : "Methods in molecular biology (eds Hill, A. & Clifton, N. J.) pp 189–196",
      "citeRegEx" : "7",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "A novel community driven software for functional enrichment analysis of extracellular vesicles data",
      "author" : [ "M Pathan" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2017
    }, {
      "title" : "Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease",
      "author" : [ "Sódar", "B. W" ],
      "venue" : "Expert. Rev. Proteom",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 2017
    }, {
      "title" : "Mass spectrometry of extracellular vesicles",
      "author" : [ "G Pocsfalvi" ],
      "venue" : "Mass. Spectrom. Rev. 35,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2016
    }, {
      "title" : "Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer",
      "author" : [ "N Wang" ],
      "venue" : "Cancer Sci. 109,",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2018
    }, {
      "title" : "Systematic comparison of exosomal proteomes from human saliva and serum for the detection of lung cancer",
      "author" : [ "Y Sun" ],
      "venue" : "Anal. Chim. Acta 982,",
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2017
    }, {
      "title" : "Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria",
      "author" : [ "L Gonzalez-Calero" ],
      "venue" : "Oncotarget 8,",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2017
    }, {
      "title" : "Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma",
      "author" : [ "A Arbelaiz" ],
      "venue" : "Hepatology 66,",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2017
    }, {
      "title" : "Exosomal proteome analysis of human plasma to monitor sepsis progression",
      "author" : [ "Y Xu" ],
      "venue" : "Biochem. Biophys. Res. Commun. 499,",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2018
    }, {
      "title" : "Detailed analysis of protein topology of extracellular vesicles-evidence of unconventional membrane protein",
      "author" : [ "A Cvjetkovic" ],
      "venue" : "orientation. Sci. Rep",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2016
    }, {
      "title" : "applications for liquid biopsies",
      "author" : [ "Amorim", "M.G. et al. A total transcriptome profiling method for plasmaderived extracellular vesicles" ],
      "venue" : "Sci. Rep. 7, 14395",
      "citeRegEx" : "17",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing",
      "author" : [ "D Buschmann" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2018
    }, {
      "title" : "Comparison of serum exosome isolation methods for microRNA profiling",
      "author" : [ "K Rekker" ],
      "venue" : "Clin. Biochem.  47,",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2014
    }, {
      "title" : "Analysis of the RNA content of the exosomes derived from blood serum and urine and its potential as biomarkers",
      "author" : [ "M Li" ],
      "venue" : "Philos. Trans. R. Soc. Lond. B. Biol",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2014
    }, {
      "title" : "Characterization of human plasma-derived exosomal RNAs by deep sequencing",
      "author" : [ "X Huang" ],
      "venue" : "BMC Genom. 14,",
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2013
    }, {
      "title" : "Massively parallel sequencing of human urinary exosome/microvesicle RNA reveals a predominance of non-coding RNA",
      "author" : [ "Miranda", "K. C" ],
      "venue" : "PLoS One 9,",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2014
    }, {
      "title" : "Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes",
      "author" : [ "Y Yagi" ],
      "venue" : "Neurosci. Lett. 636,",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2017
    }, {
      "title" : "Small RNA transcriptomes of two types of exosomes in human whole saliva determined by next generation sequencing",
      "author" : [ "Y. Ogawa", "Y. Taketomi", "M. Murakami", "M. Tsujimoto", "R. Yanoshita" ],
      "venue" : null,
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2013
    }, {
      "title" : "Nanostructural and transcriptomic analyses of human saliva derived exosomes",
      "author" : [ "V Palanisamy" ],
      "venue" : "PLoS One 5,",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2010
    }, {
      "title" : "Detection of microRNA expression in human peripheral blood microvesicles",
      "author" : [ "Hunter", "M. P" ],
      "venue" : "PLoS One 3,",
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2008
    }, {
      "title" : "Immune stimuli shape the small non-coding transcriptome of extracellular vesicles released by dendritic cells",
      "author" : [ "Driedonks", "T.A. P" ],
      "venue" : "Cell Mol. Life Sci",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2018
    }, {
      "title" : "A comprehensive, cell specific microRNA catalogue of human peripheral blood",
      "author" : [ "S Juzenas" ],
      "venue" : "Nucleic Acids Res",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2017
    }, {
      "title" : "Circulating adipocyte-derived exosomal MicroRNAs associated with decreased insulin resistance after gastric bypass",
      "author" : [ "Hubal", "M. J" ],
      "venue" : "Obes. (Silver Spring)",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2017
    }, {
      "title" : "Considerations for applying metabolomics to the analysis of extracellular vesicles",
      "author" : [ "L Palomo" ],
      "venue" : "Front. Immunol",
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2014
    }, {
      "title" : "Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression",
      "author" : [ "M Clos-Garcia" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2018
    }, {
      "title" : "Metabolomic profiling of extracellular vesicles and alternative normalization methods reveal enriched metabolites and strategies to study prostate cancer-related changes",
      "author" : [ "M Puhka" ],
      "venue" : "Theranostics 7,",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2017
    }, {
      "title" : "A novel sensitive method to measure catechol-O-methyltransferase activity unravels the  presence of this activity in extracellular vesicles released by rat hepatocytes",
      "author" : [ "E. Casal", "L. Palomo", "D. Cabrera", "J.M. Falcon-Perez" ],
      "venue" : "Front. Pharmacol",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2016
    }, {
      "title" : "Enabling metabolomics based biomarker discovery studies using molecular phenotyping of exosome-like vesicles",
      "author" : [ "T Altadill" ],
      "venue" : "PLoS One 11,",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2016
    }, {
      "title" : "Extracellular vesicles are independent metabolic units with asparaginase activity",
      "author" : [ "N Iraci" ],
      "venue" : "Nat. Chem. Biol",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2017
    }, {
      "title" : "Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism",
      "author" : [ "F Royo" ],
      "venue" : "Sci. Rep",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2017
    }, {
      "title" : "Metabolically active extracellular vesicles released from hepatocytes under drug-induced liver-damaging conditions modify serum metabolome and might affect different pathophysiological processes",
      "author" : [ "F Royo" ],
      "venue" : "Eur. J. Pharm. Sci",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2017
    }, {
      "title" : "Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles",
      "author" : [ "V Lopes-Rodrigues" ],
      "venue" : "Sci. Rep. 7,",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2017
    }, {
      "title" : "a novel biomarker in cancer detection",
      "author" : [ "Thakur", "B.K. et al. Double-stranded DNA in exosomes" ],
      "venue" : "Cell Res. 24, 766–769",
      "citeRegEx" : "39",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma",
      "author" : [ "T Vagner" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2018
    }, {
      "title" : "Astrocytes and glioblastoma cells release exosomes carrying mtDNA",
      "author" : [ "M. Guescini", "S. Genedani", "V. Stocchi", "L.F. Agnati" ],
      "venue" : "J. Neural Transm. 117,",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2010
    }, {
      "title" : "Tumour microvesicles contain retrotransposon elements and amplified oncogene",
      "author" : [ "L Balaj" ],
      "venue" : "sequences. Nat. Commun",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2011
    }, {
      "title" : "Human mast cells release extracellular vesicle-associated DNA",
      "author" : [ "G. Shelke", "C. Jang S", "Y. Yin", "C. Lässer", "J. Lötvall" ],
      "venue" : "Matters (Zürich), https://doi.org/",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2016
    }, {
      "title" : "Indication of horizontal DNA gene transfer by extracellular vesicles",
      "author" : [ "S Fischer" ],
      "venue" : "PLoS One 11,",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2016
    }, {
      "title" : "Antibiotic-induced release of small extracellular vesicles (exosomes) with surface-associated DNA",
      "author" : [ "A Németh" ],
      "venue" : "Sci. Rep",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2017
    }, {
      "title" : "isolation, identification, and characterization",
      "author" : [ "Grigor’eva", "A.E. et al. Exosomes in tears of healthy individuals" ],
      "venue" : "Biochem Suppl. Ser. B Biomed. Chem. 10, 165–172",
      "citeRegEx" : "46",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer",
      "author" : [ "C Kahlert" ],
      "venue" : "J. Biol",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2014
    }, {
      "title" : "apoptotic bodies, microvesicles, and exosomes",
      "author" : [ "Lázaro-Ibáñez", "E. et al. Different gDNA content in the subpopulations of prostate cancer extracellular vesicles" ],
      "venue" : "Prostate 74, 1379–1390",
      "citeRegEx" : "48",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "how its aberrant expression in tumors may improve therapeutic targeting",
      "author" : [ "J.P. Wang", "Hielscher", "A. Fibronectin" ],
      "venue" : "J. Cancer 8, 674–682",
      "citeRegEx" : "49",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Biological properties of extracellular vesicles and their physiological functions",
      "author" : [ "M Yáñez-Mó" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2015
    }, {
      "title" : "Transferred BCR/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice",
      "author" : [ "J Cai" ],
      "venue" : "PLoS One 9,",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2014
    }, {
      "title" : "Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras",
      "author" : [ "Lee", "T. H" ],
      "venue" : "Oncotarget 7,",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2016
    }, {
      "title" : "Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes",
      "author" : [ "San Lucas", "F. A" ],
      "venue" : "Ann. Oncol",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2016
    }, {
      "title" : "High prevalence of mutant KRAS in circulating exosomederived DNA from early stage pancreatic cancer patients",
      "author" : [ "K Allenson" ],
      "venue" : "Ann. Oncol. 28,",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2017
    }, {
      "title" : "Liquid biopsies using plasma exosomal nucleic acids and plasma cell-free DNA compared with clinical outcomes of patients with advanced cancers",
      "author" : [ "L Möhrmann" ],
      "venue" : "Clin. Cancer Res",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 2018
    }, {
      "title" : "Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer",
      "author" : [ "S Yang" ],
      "venue" : "Cancer Biol. Ther.  18,",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2017
    }, {
      "title" : "Exosome-based detection of EGFR T790M in plasma from non–small cell lung cancer patients",
      "author" : [ "E Castellanos-Rizaldos" ],
      "venue" : "Clin. Cancer Res",
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2018
    }, {
      "title" : "DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients",
      "author" : [ "N García-Romero" ],
      "venue" : "Oncotarget",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2019
    }, {
      "title" : "Bioinformatics and Biomedical Engineering (eds Rojas, I",
      "author" : [ "A. Gezsi", "B. Bruncsics", "G. Guta", "In Antal P. Constructing a Quantitative Fusion Layer over the Semantic Level for Scalable Inference." ],
      "venue" : "& Ortuño, F.) IWBBIO 2018, pp 41–53",
      "citeRegEx" : "59",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases",
      "author" : [ "N. Queralt-Rosinach", "J. Piñero", "À. Bravo", "F. Sanz", "Furlong", "L.I. DisGeNETRDF" ],
      "venue" : "Bioinformatics 32, 2236–2238",
      "citeRegEx" : "60",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "A Language and Environment for Statistical Computing",
      "author" : [ "R R. Core Team." ],
      "venue" : "R Foundation for Statistical Computing, Vienna, Austria",
      "citeRegEx" : "61",
      "shortCiteRegEx" : null,
      "year" : 2018
    }, {
      "title" : "Limma powers differential expression analyses for RNAsequencing and microarray studies",
      "author" : [ "Ritchie", "M. E" ],
      "venue" : "Nucleic Acids Res. 43,",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2015
    }, {
      "title" : "Combining multiple tools outperforms individual methods in gene set enrichment analyses",
      "author" : [ "M Alhamdoosh" ],
      "venue" : "Bioinformatics 33,",
      "citeRegEx" : "63",
      "shortCiteRegEx" : "63",
      "year" : 2017
    }, {
      "title" : "Early relapse in ALL is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways",
      "author" : [ "Meyer", "L. H" ],
      "venue" : "Cancer Cell",
      "citeRegEx" : "64",
      "shortCiteRegEx" : "64",
      "year" : 2011
    }, {
      "title" : "Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy",
      "author" : [ "Yu", "Y. P" ],
      "venue" : "J. Clin. Oncol",
      "citeRegEx" : "65",
      "shortCiteRegEx" : "65",
      "year" : 2004
    }, {
      "title" : "Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer",
      "author" : [ "A Spira" ],
      "venue" : "Nat. Med",
      "citeRegEx" : "66",
      "shortCiteRegEx" : "66",
      "year" : 2007
    }, {
      "title" : "Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions",
      "author" : [ "Parnell", "G. P" ],
      "venue" : "Shock 40,",
      "citeRegEx" : "67",
      "shortCiteRegEx" : "67",
      "year" : 2013
    }, {
      "title" : "An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma",
      "author" : [ "N Voraphani" ],
      "venue" : "Mucosal Immunol",
      "citeRegEx" : "68",
      "shortCiteRegEx" : "68",
      "year" : 2014
    }, {
      "title" : "RNA profiling analysis of the serum exosomes derived from patients with active and latent mycobacterium tuberculosis infection",
      "author" : [ "L Lv" ],
      "venue" : "Front. Microbiol",
      "citeRegEx" : "69",
      "shortCiteRegEx" : "69",
      "year" : 2017
    }, {
      "title" : "MicroRNA expression profile in exosome discriminates extremely severe infections from mild infections for hand, foot and mouth disease",
      "author" : [ "Jia", "H.-L" ],
      "venue" : "Bmc. Infect. Dis.  14,",
      "citeRegEx" : "70",
      "shortCiteRegEx" : "70",
      "year" : 2014
    }, {
      "title" : "Genome-wide profiling of urinary extracellular vesicle microRNAs associated with diabetic nephropathy in type 1 diabetes",
      "author" : [ "V Ghai" ],
      "venue" : "Kidney Int Rep",
      "citeRegEx" : "71",
      "shortCiteRegEx" : "71",
      "year" : 2018
    }, {
      "title" : "effect of glycemic control",
      "author" : [ "Santovito", "D. et al. Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes" ],
      "venue" : "J. Clin. Endocrinol. Metab. 99, E1681–E1685",
      "citeRegEx" : "72",
      "shortCiteRegEx" : null,
      "year" : 2014
    }, {
      "title" : "Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction",
      "author" : [ "S Matsumoto" ],
      "venue" : "Circ. Res",
      "citeRegEx" : "73",
      "shortCiteRegEx" : "73",
      "year" : 2013
    }, {
      "title" : "Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer",
      "author" : [ "F Royo" ],
      "venue" : "Oncotarget 7,",
      "citeRegEx" : "74",
      "shortCiteRegEx" : "74",
      "year" : 2016
    }, {
      "title" : "Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts",
      "author" : [ "X Liu" ],
      "venue" : "Breast Cancer Res. 20,",
      "citeRegEx" : "75",
      "shortCiteRegEx" : "75",
      "year" : 2018
    }, {
      "title" : "High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients",
      "author" : [ "A Conley" ],
      "venue" : "RNA Biol",
      "citeRegEx" : "76",
      "shortCiteRegEx" : "76",
      "year" : 2017
    }, {
      "title" : "promising biomarkers of colorectal cancer",
      "author" : [ "Ostenfeld", "M.S. et al. miRNA profiling of circulating EpCAM(+) extracellular vesicles" ],
      "venue" : "J. Extracell. Vesicles 5, 31488",
      "citeRegEx" : "77",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma",
      "author" : [ "Lutgendorf", "S. K" ],
      "venue" : "Cancer 124,",
      "citeRegEx" : "78",
      "shortCiteRegEx" : "78",
      "year" : 2018
    }, {
      "title" : "MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer",
      "author" : [ "D.D. Taylor", "C. Gercel-Taylor" ],
      "venue" : "Gynecol. Oncol",
      "citeRegEx" : "79",
      "shortCiteRegEx" : "79",
      "year" : 2008
    }, {
      "title" : "Exosome-derived miRNAs and ovarian carcinoma progression",
      "author" : [ "O. Vaksman", "C. Tropé", "B. Davidson", "R. Reich" ],
      "venue" : "Carcinogenesis 35,",
      "citeRegEx" : "80",
      "shortCiteRegEx" : "80",
      "year" : 2014
    }, {
      "title" : "A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis",
      "author" : [ "X Zhou" ],
      "venue" : "Oncotarget 8,",
      "citeRegEx" : "81",
      "shortCiteRegEx" : "81",
      "year" : 2017
    }, {
      "title" : "a diagnostic marker for lung cancer",
      "author" : [ "G. Rabinowits", "C. Gerçel-Taylor", "J.M. Day", "D.D. Taylor", "Kloecker", "G.H. Exosomal microRNA" ],
      "venue" : "Clin. Lung. Cancer 10, 42–46",
      "citeRegEx" : "82",
      "shortCiteRegEx" : null,
      "year" : 2009
    }, {
      "title" : "pathological and diagnostic implications",
      "author" : [ "Ragusa", "M. et al. miRNA profiling in vitreous humor", "vitreal exosomes", "serum from uveal melanoma patients" ],
      "venue" : "Cancer Biol. Ther. 16, 1387–1396",
      "citeRegEx" : "83",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Extracellular vesicle RNA sequencing reveals dramatic transcriptomic alterations between metastatic and primary osteosarcoma in a liquid biopsy approach",
      "author" : [ "Q Bao" ],
      "venue" : "Ann. Surg. Oncol",
      "citeRegEx" : "84",
      "shortCiteRegEx" : "84",
      "year" : 2018
    }, {
      "title" : "RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls",
      "author" : [ "M Noerholm" ],
      "venue" : "BMC Cancer 12,",
      "citeRegEx" : "85",
      "shortCiteRegEx" : "85",
      "year" : 2012
    }, {
      "title" : "MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer’s disease",
      "author" : [ "McKeever", "P. M" ],
      "venue" : "Mol. Neurobiol",
      "citeRegEx" : "86",
      "shortCiteRegEx" : "86",
      "year" : 2018
    }, {
      "title" : "Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis",
      "author" : [ "K Kimura" ],
      "venue" : "Nat. Commun. 9,",
      "citeRegEx" : "87",
      "shortCiteRegEx" : "87",
      "year" : 2018
    }, {
      "title" : "Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis",
      "author" : [ "I Selmaj" ],
      "venue" : "Ann. Neurol",
      "citeRegEx" : "88",
      "shortCiteRegEx" : "88",
      "year" : 2017
    }, {
      "title" : "Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through downregulation of endothelial RAB11FIP2 expression",
      "author" : [ "I Sukma Dewi" ],
      "venue" : "Cardiovasc. Res",
      "citeRegEx" : "89",
      "shortCiteRegEx" : "89",
      "year" : 2017
    }, {
      "title" : "Altered exosomal RNA profiles in bronchoalveolar lavage from lung transplants with acute rejection",
      "author" : [ "Gregson", "A. L" ],
      "venue" : "Am. J. Respir. Crit. Care. Med",
      "citeRegEx" : "90",
      "shortCiteRegEx" : "90",
      "year" : 2015
    }, {
      "title" : "Altered micro-ribonucleic acid expression profiles of extracellular microvesicles in the seminal plasma of patients with oligoasthenozoospermia",
      "author" : [ "M Abu-Halima" ],
      "venue" : "Fertil. Steril. 106,",
      "citeRegEx" : "91",
      "shortCiteRegEx" : "91",
      "year" : 2016
    }, {
      "title" : "Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure",
      "author" : [ "J.J. Gildea", "J.M. Carlson", "C.D. Schoeffel", "R.M. Carey", "R.A. Felder" ],
      "venue" : "Clin. Biochem",
      "citeRegEx" : "92",
      "shortCiteRegEx" : "92",
      "year" : 2013
    }, {
      "title" : "microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy",
      "author" : [ "C. Belleannée", "C. Légaré", "E. Calvo", "V. Thimon", "R. Sullivan" ],
      "venue" : "Hum. Reprod",
      "citeRegEx" : "93",
      "shortCiteRegEx" : "93",
      "year" : 2013
    }, {
      "title" : "Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)",
      "author" : [ "R.M. Johnstone", "M. Adam", "J.R. Hammond", "L. Orr", "C. Turbide" ],
      "venue" : "J. Biol",
      "citeRegEx" : "94",
      "shortCiteRegEx" : "94",
      "year" : 1987
    }, {
      "title" : "evidence precluding a role for “aminophospholipid translocase",
      "author" : [ "M. Vidal", "J. Sainte-Marie", "J.R. Philippot", "Bienvenue", "A. Asymmetric distribution of phospholipids in the membrane of vesicles released during in vitro maturation of guinea pig reticulocytes" ],
      "venue" : "J. Cell Physiol. 140, 455–462",
      "citeRegEx" : "95",
      "shortCiteRegEx" : null,
      "year" : 1989
    }, {
      "title" : "Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells",
      "author" : [ "O Fourcade" ],
      "venue" : "Cell 80,",
      "citeRegEx" : "96",
      "shortCiteRegEx" : "96",
      "year" : 1995
    }, {
      "title" : "Phospholipid composition of cell-derived microparticles determined by one-dimensional highperformance thin-layer chromatography",
      "author" : [ "A.M. Weerheim", "A.M. Kolb", "A. Sturk", "R. Nieuwland" ],
      "venue" : "Anal. Biochem. 302,",
      "citeRegEx" : "97",
      "shortCiteRegEx" : "97",
      "year" : 2002
    }, {
      "title" : "Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization",
      "author" : [ "K Laulagnier" ],
      "venue" : "Biochem. J. 380,",
      "citeRegEx" : "98",
      "shortCiteRegEx" : "98",
      "year" : 2004
    }, {
      "title" : "Microenvironmental pH is a key factor for exosome traffic in tumor cells",
      "author" : [ "I Parolini" ],
      "venue" : "J. Biol. Chem. 284,",
      "citeRegEx" : "99",
      "shortCiteRegEx" : "99",
      "year" : 2009
    }, {
      "title" : "Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins",
      "author" : [ "C Subra" ],
      "venue" : "J. Lipid Res",
      "citeRegEx" : "100",
      "shortCiteRegEx" : "100",
      "year" : 2010
    }, {
      "title" : "A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients",
      "author" : [ "M Bourderioux" ],
      "venue" : "J. Proteome Res",
      "citeRegEx" : "101",
      "shortCiteRegEx" : "101",
      "year" : 2015
    }, {
      "title" : "comparative characterization of Haemophilus influenzae outer membrane vesicles",
      "author" : [ "Roier", "S. et al. A basis for vaccine development" ],
      "venue" : "Int. J. Med. Microbiol. 305, 298–309",
      "citeRegEx" : "102",
      "shortCiteRegEx" : null,
      "year" : 2015
    }, {
      "title" : "Pellet-free isolation of human and bovine milk extracellular vesicles by size-exclusion chromatography",
      "author" : [ "K Blans" ],
      "venue" : "J. Extracell. Vesicles  6,",
      "citeRegEx" : "103",
      "shortCiteRegEx" : "103",
      "year" : 2017
    }, {
      "title" : "PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes",
      "author" : [ "K Laulagnier" ],
      "venue" : "FEBS Lett. 572,",
      "citeRegEx" : "104",
      "shortCiteRegEx" : "104",
      "year" : 2004
    }, {
      "title" : "Proteolipidic composition of exosomes changes during reticulocyte maturation",
      "author" : [ "K Carayon" ],
      "venue" : "J. Biol. Chem. 286,",
      "citeRegEx" : "105",
      "shortCiteRegEx" : "105",
      "year" : 2011
    }, {
      "title" : "Distinct lipid compositions of two types of human prostasomes",
      "author" : [ "Brouwers", "J. F" ],
      "venue" : "Proteomics 13,",
      "citeRegEx" : "106",
      "shortCiteRegEx" : "106",
      "year" : 2013
    }, {
      "title" : "Extracellular vesicles from human pancreatic islets suppress human islet amyloid polypeptide amyloid formation",
      "author" : [ "D Ribeiro" ],
      "venue" : "Proc. Natl Acad. Sci. USA",
      "citeRegEx" : "107",
      "shortCiteRegEx" : "107",
      "year" : 2017
    }, {
      "title" : "Lipidomic analysis of extracellular vesicles from the pathogenic phase of Paracoccidioides brasiliensis",
      "author" : [ "Vallejo", "M. C" ],
      "venue" : "PLoS One 7,",
      "citeRegEx" : "108",
      "shortCiteRegEx" : "108",
      "year" : 2012
    }, {
      "title" : "Lipidomic analysis of human placental syncytiotrophoblast microvesicles in adverse pregnancy outcomes",
      "author" : [ "S Baig" ],
      "venue" : "Placenta 34,",
      "citeRegEx" : "109",
      "shortCiteRegEx" : "109",
      "year" : 2013
    }, {
      "title" : "Biochemical and biological characterization of exosomes containing prominin-1/CD133",
      "author" : [ "G. Rappa", "J. Mercapide", "F. Anzanello", "R.M. Pope", "A. Lorico" ],
      "venue" : "Mol. Cancer 12,",
      "citeRegEx" : "110",
      "shortCiteRegEx" : "110",
      "year" : 2013
    }, {
      "title" : "Molecular lipidomics of exosomes released by PC-3 prostate cancer cells",
      "author" : [ "A Llorente" ],
      "venue" : "Biochim. Biophys. Acta 1831,",
      "citeRegEx" : "111",
      "shortCiteRegEx" : "111",
      "year" : 2013
    }, {
      "title" : "Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets",
      "author" : [ "A Pienimaeki-Roemer" ],
      "venue" : "Transfusion 55,",
      "citeRegEx" : "112",
      "shortCiteRegEx" : "112",
      "year" : 2015
    }, {
      "title" : "Rapid and comprehensive ‘shotgun’ lipidome profiling of colorectal cancer cell derived exosomes",
      "author" : [ "Lydic", "T. A" ],
      "venue" : "Methods 87,",
      "citeRegEx" : "113",
      "shortCiteRegEx" : "113",
      "year" : 2015
    }, {
      "title" : "High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources",
      "author" : [ "Haraszti", "R. A" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "114",
      "shortCiteRegEx" : "114",
      "year" : 2016
    }, {
      "title" : "Lipid profile of platelets and platelet-derived microparticles in ovarian cancer",
      "author" : [ "Q Hu" ],
      "venue" : "BBA Clin",
      "citeRegEx" : "115",
      "shortCiteRegEx" : "115",
      "year" : 2016
    }, {
      "title" : "Isolation of human trophoblastic extracellular vesicles and characterization of their cargo and antiviral activity",
      "author" : [ "Y Ouyang" ],
      "venue" : "Placenta 47,",
      "citeRegEx" : "116",
      "shortCiteRegEx" : "116",
      "year" : 2016
    }, {
      "title" : "Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles",
      "author" : [ "M Durcin" ],
      "venue" : "J. Extracell. Vesicles",
      "citeRegEx" : "117",
      "shortCiteRegEx" : "117",
      "year" : 2017
    }, {
      "title" : "Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites",
      "author" : [ "D Braig" ],
      "venue" : "Nat. Commun",
      "citeRegEx" : "118",
      "shortCiteRegEx" : "118",
      "year" : 2017
    }, {
      "title" : "Lipidomic and proteomic analysis of exosomes from mouse cortical collecting duct cells",
      "author" : [ "V.D. Dang", "K.K. Jella", "R.R.T. Ragheb", "N.D. Denslow", "A.A. Alli" ],
      "venue" : "FASEB J. 31,",
      "citeRegEx" : "119",
      "shortCiteRegEx" : "119",
      "year" : 2017
    }, {
      "title" : "Unique lipid signatures of extracellular vesicles from the airways of asthmatics",
      "author" : [ "Hough", "K. P" ],
      "venue" : "Sci. Rep. 8,",
      "citeRegEx" : "120",
      "shortCiteRegEx" : "120",
      "year" : 2018
    }, {
      "title" : "Comparative lipidomic profiling of the human commensal bacterium Propionibacterium acnes and its extracellular vesicles",
      "author" : [ "J Jeon" ],
      "venue" : "RSC Adv",
      "citeRegEx" : "121",
      "shortCiteRegEx" : "121",
      "year" : 2018
    }, {
      "title" : "Hydrogen peroxide stimulates exosomal cathepsin B regulation of the receptor for advanced glycation end-products (RAGE)",
      "author" : [ "C.A. Downs", "V.D. Dang", "N.M. Johnson", "N.D. Denslow", "A.A. Alli" ],
      "venue" : "J. Cell Biochem",
      "citeRegEx" : "122",
      "shortCiteRegEx" : "122",
      "year" : 2018
    }, {
      "title" : "Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid",
      "author" : [ "Miranda", "A. M" ],
      "venue" : "signatures. Nat. Commun. 9,",
      "citeRegEx" : "123",
      "shortCiteRegEx" : "123",
      "year" : 2018
    }, {
      "title" : "The HDAC6 inhibitor tubacin induces release of CD133 +extracellular vesicles from cancer cells",
      "author" : [ "Chao", "O. S" ],
      "venue" : "J. Cell. Biochem",
      "citeRegEx" : "124",
      "shortCiteRegEx" : "124",
      "year" : 2017
    }, {
      "title" : "HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin",
      "author" : [ "L. Krishnamoorthy", "J.W. Bess", "A.B. Preston", "K. Nagashima", "L.K. Mahal" ],
      "venue" : "Nat. Chem. Biol",
      "citeRegEx" : "125",
      "shortCiteRegEx" : "125",
      "year" : 2009
    }, {
      "title" : "Identification of a conserved glycan signature for microvesicles",
      "author" : [ "B.S. Batista", "W.S. Eng", "K.T. Pilobello", "K.D. Hendricks-Muñoz", "L.K. Mahal" ],
      "venue" : "J. Proteome Res",
      "citeRegEx" : "126",
      "shortCiteRegEx" : "126",
      "year" : 2011
    }, {
      "title" : "Importance of sugar recognition for cellular uptake of exosomes from mesenchymal stem cells",
      "author" : [ "A. Shimoda", "Y. Tahara", "Sawada", "S.-I.", "Y. Sasaki", "Akiyoshi", "K. Glycan profiling analysis using evanescent-field fluorescence-assisted lectin array" ],
      "venue" : "Biochem. Biophys. Res. Commun. 491, 701–707",
      "citeRegEx" : "127",
      "shortCiteRegEx" : null,
      "year" : 2017
    }, {
      "title" : "Development of a lectin microarray for the rapid analysis of protein glycopatterns",
      "author" : [ "K.T. Pilobello", "L. Krishnamoorthy", "D. Slawek", "L.K. Mahal" ],
      "venue" : "Chembiochem 6,",
      "citeRegEx" : "128",
      "shortCiteRegEx" : "128",
      "year" : 2005
    }, {
      "title" : "Microarray-based identification of lectins for the purification of human urinary extracellular vesicles directly from urine samples",
      "author" : [ "J Echevarria" ],
      "venue" : "Chembiochem 15,",
      "citeRegEx" : "129",
      "shortCiteRegEx" : "129",
      "year" : 2014
    }, {
      "title" : "Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells",
      "author" : [ "C Escrevente" ],
      "venue" : "PLoS One 8,",
      "citeRegEx" : "130",
      "shortCiteRegEx" : "130",
      "year" : 2013
    }, {
      "title" : "Extracellular vesicles from ovarian carcinoma cells display specific glycosignatures",
      "author" : [ "J Gomes" ],
      "venue" : "Biomolecules  5,",
      "citeRegEx" : "131",
      "shortCiteRegEx" : "131",
      "year" : 2015
    }, {
      "title" : "Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression",
      "author" : [ "Nyalwidhe", "J. O" ],
      "venue" : "Proteom. Clin. Appl",
      "citeRegEx" : "132",
      "shortCiteRegEx" : "132",
      "year" : 2013
    }, {
      "title" : "Differential glycomics of epithelial membrane glycoproteins from urinary exovesicles reveals shifts toward complex-type N-glycosylation in classical galactosemia",
      "author" : [ "S. Staubach", "P. Schadewaldt", "U. Wendel", "K. Nohroudi", "Hanisch", "F.-G" ],
      "venue" : "J. Proteome Res",
      "citeRegEx" : "133",
      "shortCiteRegEx" : "133",
      "year" : 2012
    }, {
      "title" : "Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation",
      "author" : [ "H Zhang" ],
      "venue" : "Nat. Cell Biol",
      "citeRegEx" : "134",
      "shortCiteRegEx" : "134",
      "year" : 2019
    } ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "Extracellular vesicles (EVs) are membrane-enclosed structures secreted by cells. In the past decade, EVs have attracted substantial attention as carriers of complex intercellular information. They have been implicated in a wide variety of biological processes in health and disease. They are also considered to hold promise for future diagnostics and therapy. EVs are characterized by a previously underappreciated heterogeneity. The heterogeneity and molecular complexity of EVs necessitates high-throughput analytical platforms for detailed analysis. Recently, mass spectrometry, nextgeneration sequencing and bioinformatics tools have enabled detailed proteomic, transcriptomic, glycomic, lipidomic, metabolomic, and genomic analyses of EVs. Here, we provide an overview of systems biology experiments performed in the field of EVs. Furthermore, we provide examples of how in silico systems biology approaches can be used to identify correlations between genes involved in EV biogenesis and human diseases. Using a knowledge fusion system, we investigated whether certain groups of proteins implicated in the biogenesis/release of EVs were associated with diseases and phenotypes. Furthermore, we investigated whether these proteins were enriched in publicly available transcriptomic datasets using gene set enrichment analysis methods. We found associations between key EV biogenesis proteins and numerous diseases, which further emphasizes the key role of EVs in human health and disease.",
    "creator" : "Springer"
  }
}